Our research projects

Not everyone with diabetes is diagnosed with the right type straight away. Professor Angus Jones wants to shed more light on how common misdiagnosis is and who could benefit from extra checks by analysing data from a large health study, called the UK Biobank. His insights could help more people with diabetes to get the right diagnosis, and the right care and advice. 

It’s not always easy to diagnose which type of diabetes a person has. This is because the symptoms and test results can overlap, particularly in people from some ethnic groups. In this project, Professor Shields will improve calculators used to get the diagnosis right in many more people with diabetes. 

Established in 2011, ADDRESS-2 is a database of information from of people newly diagnosed with type 1 diabetes who have agreed to be involved in research. This new funding will continue to support the program and allow the team recruit more people. The team will work with the type 1 diabetes Immunotherapy Consortium to increase the number of people recruited into immunotherapy trials. These trials aim to find new ways to prevent, or cure, type 1 diabetes.

Obesity and type 2 diabetes can both harm the kidneys. Dr Li Kang has discovered a group of molecules that may be involved in this process. She will now investigate whether blocking these molecules could help protect the kidneys from damage in people living with obesity and type 2 diabetes.

Diabetic foot ulcers can have a huge impact on people’s lives, and, in the most serious cases, infections can put people at risk of life-altering amputations. Dr Wilkinson wants to understand how bacteria cause infections and slow healing in foot ulcers in people with type 2 diabetes. This will help to develop new treatments that could protect people with diabetes against amputations.

Type 1 diabetes develops when the immune system attacks and destroys insulin-making beta cells. Dr Mark Russell and his PhD student will test existing drugs that could help to hide and protect beta cells from attack. This could lead to a new way to slow down type 1 diabetes, giving people more time with their own insulin and protecting their future health. In the longer term, the drugs could also help to cure type 1 diabetes. 

Some people with diabetes go on to develop problems with the nerves in their feet. This is known as peripheral neuropathy and can affect safe driving. Professor Marple-Horvat is investigating if a driving stimulator and feedback system can help people with peripheral neuropathy get back to driving safely again, and keep their independence.

Insulin-making beta cells in people with type 2 diabetes can stop working properly due to toxic molecules. Dr Catherine Arden wants to explore what causes this by measuring what happens when sugar and fat are added to beta cells. Understanding more about this process will help researchers to develop new treatments that can prevent damage to beta cells. This could slow down the progression of type 2 diabetes and reduce the risk of complications for people living with type 2 diabetes. 

Many people who use metformin to manage their type 2 diabetes, often need to start on a second medication to control blood sugar levels. Dr Beall wants to better understand the effect of metformin in the brain and why this may cause some people with type 2 to stop responding to it over time. He’ll also shed new light on if and how metformin may have anti-inflammatory effects in the brain. In the future this could help us to understand who is more likely to need an add on treatment and open-up new ways to keep the brain healthy in people with diabetes. 

When the immune system attacks the pancreas in type 1 diabetes, the body responds with inflammation which can damage insulin-producing beta cells. Transplants of pancreas cells, called islet transplants, can be used to treat some people with type 1 diabetes, but they don’t always work. Dr Chloe Rackham wants to understand how shape-shifting stem cells can protect transplanted cells from damage caused by inflammation. This could help to make islet transplants more successful in the future and could open up ways to delay or prevent type 1 diabetes.